On Dec. 11, 2025, the California Institute for Regenerative Medicine (CIRM) governing board approved funding of over $160…
On Dec. 5, 2025, Amneal Pharmaceuticals announced new positive interim results from its ongoing Phase 4 ELEVATE-PD study….
On Nov. 12, 2025, Allen Institute researchers and engineers have unlocked an the world’s most comprehensive AI-powered tool…
On Oct. 30, 2025, the California Institute for Regenerative Medicine (CIRM) approved awarding $27 million through three grants…
On Oct. 29, 2025, Rice University announced the creation of the Rice Brain Institute (RBI), an ambitious, interdisciplinary…
On Oct. 6, 2025, Researchers at the University of Bath, in collaboration with the Universities of Oxford and…
On Sept. 2, 2025, Arrowhead Pharmaceuticals announced a global licensing and collaboration agreement with Novartis for ARO-SNCA, Arrowhead’s…
On Jul. 28, 2025, a study published in Nature Neuroscience shows that potential contact with approaching infectious avatars,…
On Jun. 30, 2025, a University of Oxford led study reported that a drug used for Parkinson’s disease…
On Mar. 14, 2025, researchers from the Walter and Eliza Hall Institute of Medical Research (WEHI) announced they…
On Dec. 23, 2024, a study from Radboud University reported that the standard medication levodopa does not always…
On Oct. 21, 2024, in one of the largest-ever studies of DNA and brain volume, researchers announced they…
On Sept. 30, 2024, Amneal Pharmaceuticals announced that it had launched CREXONT ® (carbidopa and levodopa) extended-release capsules…
On Sept. 26. 2024, a team of scientists led by Prof. Patrik Verstreken at the VIB-KU Leuven Center…
On Aug. 21, 2024, Contrary to previous research, a new study of female participants finds no link between…
On Aug. 7, 2024, Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) had approved CREXONT…
On May 30, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had awarded $53 million to…
On May 29, 2024, 23andMe with support from The Michael J. Fox Foundation for Parkinson’s Research, announced it…
Milestones in Parkinson’s illustrates advancements in the disease from James Parkinson’s essay on ‘shaking palsy’ to development of…
On Apr. 13, 2023, in an enormous leap forward in the understanding of Parkinson’s disease (PD), researchers announced…
On Apr. 22, 2022, Stanford University announced it was awarded a $75 million gift from Nike co-founder Phil…
On Feb. 8, 2022, researchers at Oxford University announced they had implanted a novel closed-loop research platform for…
On Jun. 1, 2021, Sanofi announced that Vaxelis (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus…
On Feb. 16, 2021, in a study led by National Institutes of Health (NIH) researchers, scientists found that…
On Oct. 10, 2019, University of Pennsylvania (UPenn) researchers announced they had received a $20 million National Institutes…
On Aug. 24, 2017, Adamas announced U.S. Food and Drug Administration (FDA) approval of GOCOVRI as First and…
In 2016, the Tianqiao and Chrissy Chen Institute for Neuroscience at Caltech was founded with a $1 billion…
On Oct. 1, 2015, The Kavli Foundation announced a $20 million award to establish the Kavli Neural Systems…
On Oct. 1, 2015, The Kavli Foundation announced a $20 million award to establish the Institute for Fundamental…
On Jun. 26, 2015, The Keck School of Medicine announced it had established the University of Southern California…